Drug Screening Assays, AntitumorXenograft Model Antitumor AssaysAntineoplastic AgentsCell Line, TumorLeukemia P388Antibiotics, AntineoplasticMice, NudeSarcoma 180Neoplasms, ExperimentalNeoplasm TransplantationMelanoma, ExperimentalCancer VaccinesMice, Inbred BALB CTumor Cells, CulturedNeoplasmsLeukemia L1210ImmunotherapyMice, Inbred C57BLImmunotherapy, AdoptiveDrug SynergismEnediynesApoptosisMice, SCIDCell ProliferationTransplantation, HeterologousCarcinoma, Lewis LungAntineoplastic Agents, PhytogenicAntigens, NeoplasmDose-Response Relationship, DrugInjections, IntralesionalOncolytic VirotherapyGenetic TherapyCytotoxicity, ImmunologicSarcoma, ExperimentalMelanomaAntibodies, MonoclonalT-Lymphocytes, CytotoxicCell SurvivalFibrosarcomaLung NeoplasmsOncolytic VirusesColonic NeoplasmsCD8-Positive T-LymphocytesTumor BurdenAngiogenesis InhibitorsDendritic CellsKiller Cells, NaturalInhibitory Concentration 50AdenoviridaeDoxorubicinCell DivisionLymphocytes, Tumor-InfiltratingImmunotoxinsNeovascularization, PathologicGenetic VectorsMice, Inbred DBAAntineoplastic Combined Chemotherapy ProtocolsMammary Neoplasms, ExperimentalEllipticinesFlow CytometryStreptomycesMolecular StructureInterferon-gammaCisplatinInterleukin-2Carcinoma, Ehrlich TumorInterleukin-12T-LymphocytesCamptothecinProdrugsNaphthacenesAntineoplastic Agents, AlkylatingDrug Administration ScheduleIndolesCombined Modality TherapyTumor EscapeStructure-Activity RelationshipIntercalating AgentsZinostatinDrug Evaluation, PreclinicalDrug Resistance, NeoplasmTopoisomerase I InhibitorsMice, Inbred C3HLymphocyte ActivationLeukemia L5178PaclitaxelLeukemia, ExperimentalCell Growth ProcessesPlicamycinAntibodies, NeoplasmCell CycleBreast NeoplasmsQuinazolinesAdjuvants, ImmunologicSignal TransductionTime FactorsProtein Kinase InhibitorsImmunotherapy, ActiveAntibody-Dependent Cell CytotoxicityOvarian Neoplasms